N-of-1 in ATS and MEPPC

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Andersen Tawil SyndromeMultifocal Ectopic Purkinje-related Premature Contractions
Interventions
DRUG

Flecainide

Flecainide monotherapy

DRUG

Flecainide + beta-blocker

Flecainide + beta-blocker

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER